Ledger.Open graph →
SEC Form D · filed April 1, 2016

ESSA Pharma Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Scott Requadt · Cambridge, MADirectorDavid Wood · Vancouver, British Columbia, CanadaExecDale T. Zajicek · Houston, TXDirectorRichard Glickman · Vancouver, British Columbia, CanadaDirectorMarianne Sadar · Vancouver, British Columbia, CanadaExec · DirectorPaul Cossum · Houston, TXExecFranklin Berger · San Francisco, CADirectorGary Sollis · Vancouver, British Columbia, CanadaDirectorRaymond Andersen · Vancouver, British Columbia, CanadaExec · DirectorFrank Perabo · Houston, TXExecDavid Parkinson · Gaithersburg, MDExecDavid Wood · Langley, British Columbia, CanadaExecGary Economo · Kingston, Ontario, CanadaDirectorRichard Glickman · Vancouver, British Columbia, CanadaDirectorMarianne Sadar · Vancouver, British Columbia, CanadaExec · DirectorPaul Cossum · Houston, TXExecFranklin Berger · Framingham, MADirectorGary Sollis · Vancouver, British Columbia, CanadaDirectorRaymond Andersen · Vancouver, British Columbia, CanadaExec · DirectorFrank Perabo · Houston, TXExecDavid Parkinson · Houston, TXExecDavid Wood · Englewood, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗